Literature DB >> 23929786

Beta-blockers in cirrhosis patients with refractory ascites.

Anne Robins1, Anne Bowden, William Watson, Fiona Smith, William Gelson, William Griffiths.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 23929786     DOI： 10.1002/hep.26676

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  5 in total

1.  Nonselective β-blockers may induce development of portal vein thrombosis in cirrhosis.

Authors:  Xing-Shun Qi; Ming Bai; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

Review 2.  Rethinking the role of non-selective beta blockers in patients with cirrhosis and portal hypertension.

Authors:  Alberto Ferrarese; Alberto Zanetto; Giacomo Germani; Patrizia Burra; Marco Senzolo
Journal:  World J Hepatol       Date:  2016-08-28

3.  Non-selective β-blockers in advanced cirrhosis: a critical review of the effects on overall survival and renal function.

Authors:  Sara Blasco-Algora; José Masegosa-Ataz; Sonia Alonso; Maria-Luisa Gutiérrez; Conrado Fernández-Rodriguez
Journal:  BMJ Open Gastroenterol       Date:  2016-12-09

Review 4.  Beta-blockers in cirrhosis: Evidence-based indications and limitations.

Authors:  Susana G Rodrigues; Yuly P Mendoza; Jaime Bosch
Journal:  JHEP Rep       Date:  2019-12-20

5.  Degree of Portal and Systemic Hemodynamic Alterations Predict Recurrent AKI and Chronic Kidney Disease in Patients With Cirrhosis.

Authors:  Rakhi Maiwall; Samba Siva Rao Pasupuleti; Priyanka Jain; Shiv Kumar Sarin
Journal:  Hepatol Commun       Date:  2020-11-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.